CD38 and triple-negative breast carcinoma: To evaluate the impact of plasma cell infiltration in the below-mentioned cohort of triple-negative breast cancer patients, the plasma cell markers CD38 and IgκC were analyzed via immunohistochemistry using a semi-quantitative scoring method as previously described in [25,26].